Duopharma posts higher Q1 net profit, vaccine deal to boost FY21 earnings

KUALA LUMPUR: Duopharma Biotech Bhd said earnings climbed in the first quarter of stronger demand for healthcare products.

Net profit rose 30% to RM17.6mil from RM13.56mil a year ago. Revenue improved 5% to RM166mil.

Get 30% off with our ads free Premium Plan!

~~RM13.90/month~~
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

~~RM12.33/month~~
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

Free Trial

For new subscribers only

Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

Topic:

Corporate News

Report it to us.

What is the issue about?

Spelling and grammatical error

Factually incorrect

Story is irrelevant

Email (optional)